Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Daniel Lochner currently holds 24,250 shares of Oyster Point Pharma, Inc. (OYST), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel Lochner has been a net buyer of OYST stock. They have purchased $230.5K and sold $0 worth of shares.
Daniel Lochner's most recent insider trade was on Mar 4, 2026, when they sold 24,250 shares at $0.00 per share.
Daniel Lochner serves as Executive at Oyster Point Pharma, Inc. (OYST). They have executed 19 insider transactions totaling $230.5K over their tenure at the company.
Daniel Lochner holds the position of Executive at Oyster Point Pharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Daniel Lochner has shown a buying trading pattern, with $230.5K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Daniel Lochner was on Feb 10, 2026, when they purchased $129.7K worth of TECX shares. This transaction involved 6,000 shares at $21.61 per share.
Daniel Lochner currently owns 24,250 shares of Oyster Point Pharma, Inc. (OYST), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Daniel Lochner's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Daniel Lochner has 19 Form 4 filings on record as an insider at Oyster Point Pharma, Inc..
Set alerts for Daniel Lochner and 40,000+ other insiders.